SCHEMBL22761285

SCHEMBL22761285

N#Cc1cccc(-c2ccc(-n3c4cc(-c5ccc(C(F)(F)F)cc5C(F)(F)F)ccc4c4ccc(-c5ccc(C(F)(F)F)cc5C(F)(F)F)cc43)c(C(F)(F)F)c2-n2c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc3c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ CETP P11597 1/20 0.36
▸ PTPN5 P54829 1/20 0.35
▸ PRF1 P14222 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ GRIN1 Q05586 2/20 0.34
▸ GRIN2B Q13224 2/20 0.34
▸ MAT2A P31153 2/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ TRPA1 O75762 1/20 0.33
▸ ENPP1 P22413 1/20 0.33
▸ ALOX5AP P20292 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ EDNRB P24530 1/20 0.32
▸ EDNRA P25101 1/20 0.32
▸ AR P10275 1/20 0.32
▸ KIF11 P52732 1/20 0.32
▸ CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22761134 0.96 PTGDR2 (0.35) PTGDR2CETPPTPN5PRF1CYP2C9
SCHEMBL22761283 0.93 PTGDR2 (0.38) PTGDR2CETPPTPN5PRF1CYP2C9
SCHEMBL22760862 0.92 PTGDR2 (0.41) PTGDR2CETPPTPN5PRF1SCN9A
SCHEMBL22761132 0.91 PTGDR2 (0.35) PTGDR2CETPPTPN5PRF1CYP2C9
SCHEMBL22761212 0.90 PDK2 (0.41) PTGDR2CETPPTPN5PRF1GRIN1
SCHEMBL21546971 0.89 PTPN5 (0.39) PTGDR2CETPPTPN5PRF1CYP2C9
SCHEMBL22761139 0.89 CETP (0.38) PTGDR2CETPPTPN5PRF1GRIN1
SCHEMBL21547045 0.89 KIF11 (0.39) PTGDR2CETPPTPN5PRF1GRIN1
SCHEMBL22761192 0.88 PDK2 (0.39) PTGDR2CETPPTPN5PRF1GRIN1
SCHEMBL21546522 0.87 PDK2 (0.41) PTGDR2PTPN5PRF1CYP2C9PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 — — US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM PTGDR2 379/4885CETP 3548/4885PTPN5 4550/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM PTGDR2 379/4885CETP 3548/4885PTPN5 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback